Emerging antiobesity drugs in development Numerous novel treatments for obesity are currently in the pipeline, including triple agonists that target GLP-1, GIP, and glucagon receptors [26]
If that liquid contains bacteria, fungi, or endotoxins, the body must fight that contamination without the benefit of the skin barrier that normally keeps pathogens out
Oprah Winfrey shares the type of weight loss medication she took Oprah Winfrey revealed on "The Oprah Podcast" that she took a GLP-1 agonist, a type of weight-loss medication, to help manage her weight
You never know what piece of the puzzle might change everything, he said.
MariTide lands between Wegovy and Zepbound on weight loss, but wins on dosing burden as it is a once-monthly (or less frequently) injection
In this study, we successfully treated a severely obese, adolescent PWS patient with multidisciplinary management and GLP-1 receptor agonist use